Erinacin refers to a group of cyathane-type diterpenoids found primarily in the mycelium of Hericium erinaceus (Lion’s Mane mushroom). These compounds, especially Erinacin A, are known for their potent ability to stimulate Nerve Growth Factor (NGF) synthesis in the brain, making them candidates for neuroprotective, nootropic, and anti-neurodegenerative therapies. Erinacins are studied for their potential in treating Alzheimer’s disease, Parkinson’s disease, and cognitive decline.
Erinacins are typically available in dietary supplements, nutraceuticals, or research compounds and are not yet approved as pharmaceutical drugs.
Therapeutic indications (investigational/functional foods):
• Cognitive enhancement and memory support
• Supportive therapy for neurodegenerative conditions
• NGF modulation and neural repair
• Anti-inflammatory and antioxidant effects in the brain
Impurities in erinacin preparations typically arise from fermentation-based extraction, mycelial contamination, and purification challenges due to their complex tricyclic structure. Given the lack of a pharmacopeial monograph, quality standards depend on in-house specifications, nutraceutical-grade guidelines, and ICH Q3A/Q3C/Q3D for potential future drug development.
Process-Related Impurities
• Co-extracted compounds from Hericium erinaceus (e.g., hericenones, polysaccharides)
• Incomplete purification leading to related erinacins (B, C, E, G)
• Residual solvents used in extraction (e.g., ethanol, methanol, acetone)
• Fermentation by-products from fungal metabolism
Degradation Impurities
• Oxidation of the tricyclic diterpene backbone
• Hydrolysis of ester or alcohol functional groups
• Light-sensitive degradation causing discoloration
• Loss of biological activity due to structural rearrangement
Elemental Impurities
• Trace heavy metals like lead, arsenic, mercury, and cadmium from fungal substrate or water
• Should comply with USP <233> or ICH Q3D if intended for human consumption
Analytical Techniques for Impurity Detection
Erinacins are studied for their neuroprotective properties and potential to stimulate nerve growth factor (NGF), supporting brain health and cognitive function.
Preliminary studies suggest good tolerability, but long-term safety data in humans are limited. Quality and purity vary widely across supplement products.
Erinacins are found in the mycelium and are more potent in NGF stimulation, while hericenones come from the fruiting body of the mushroom.
Yes. They are sensitive to oxidation, light, and heat, which can reduce potency and generate unknown degradants.
Store in a cool, dark, and dry place. Airtight containers with light-protective packaging are recommended to preserve stability.
